Metagenomic Sequencing Market Size Estimation, Share, Future Trends, Market Statistics, Insights and key Players By 2023 |GATC Biotech AG (Germany), Enterome Bioscience (France), Illumina Inc. (U.S.)

 

Metagenomic Sequencing Market Overview

Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA. The function of metagenomic sequencing which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.

Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria. Currently, the metagenomic sequencing market is growing pervasively. The dominant factors driving this growth include the rising awareness of genetic disorders, advanced technological platforms, and the availability of improved genomic tools. Moreover, the continually dropping prices of this process are escalating the market on the global platform, encouraging people to undergo the genetic tests.

Acknowledging the exponential growth this market is witnessing today, Market Research Future (MRFR), in its recently published study report asserts that the global metagenomic sequencing market will further garner enormous gains by 2023, registering approximately 6.5% CAGR throughout the forecast period (2017 – 2023). The market demonstrates vast opportunities for service providers and companies with a great scope of expanding to enter the untapped regions by making these procedures affordable.


Additional factors fostering the growth of the market include the use of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and the development of cost-effective technologies such as next-generation sequencing (NGS). Moreover, increasing R&D activities to identify new antibiotics and enzymes, and improved bioinformatics support market growth, offering some attractive opportunities to the key market players.

Conversely, factors such as the rising concerns related to the standardization and accuracy of diagnostic testing alongside the lack of skilled professionals and knowledge are expected to impede the market growth over the forecast period. Nevertheless, public and private funding programs that are rapidly increasing are expected to support the market growth providing sufficient funds for R&D

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/5598

Metagenomic Sequencing Market   - Segmentation

MRFR has segmented the report into four key dynamics for an easy grasp;

  • Sequencing and Bioinformatics among others.
  • Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among others.
  • Hospitals, Research Institutes, and Specialized Clinics among others.                                                                 
  • North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).

Metagenomic Sequencing Market   - Regional Analysis


The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for R&D activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.

Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.

The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.

Heading with the significant advancements of technologies and their wide uptake in the medical sector, the metagenomic sequencing market in the European region holds the second position in terms of size.

Moreover, the presence of a flourishing medical devices market and rising healthcare expenditure in the region will facilitate the growth of the market. Also, factors such as support and funding from public & private sectors for research & development impacts the market growth in the region positively.

Furthermore, the availability of low-cost metagenomic and NGS procedures and their rising adoption by research laboratories are driving the growth of this market.

The Asia Pacific region heading with the increasing prevalence of genetic disorders has emerged as a promising market for metagenomic sequencing. The large unmet clinical needs are attracting the foreign investors and global players to focus on this region to expand the network that is helping them to capture major share of the market.

With the rising demand for metagenomic sequencing and increasing adoption of these techniques in various procedures, the APAC market is estimated to take over the European market soon.

Global Metagenomic Sequencing Market - Competitive Analysis


The fiercely competitive metagenomic Sequencing market appears to be fragmented with many large and small-scale players alongside the new entrants forming the competitive landscape. New technology launch, innovation, and brand reinforcement remain the popular trends for the key players in the market. The growth statistics of the metagenomic sequencing market presage the probable heights the market can reach further.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more